The Prescription Only Medicines (Human Use) Amendment Order 1998

Amendment of Schedule 1 to the principal Order

3.  In Schedule 1 to the principal Order (which specifies substances which if included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)—

(a) in relation to the substance Hydrocortisone, there are inserted in the entry in column 3, after the word “Clotrimazole”, the words “or Miconazole Nitrate”;

(b) in relation to the substance Mebeverine Hydrochloride, there are substituted for the entry in column 3 the following entries—

“(a) For the symptomatic relief of irritable bowel syndrome

(b) For uses other than the symptomatic relief of irritable bowel syndrome”

and for the entry in column 4 the following entries—

“(a) 135 mg (MD)

405 mg (MDD)

(b) 100 mg (MD)

300 mg (MDD)”;

(c) in relation to the substance Ranitidine Hydrochloride, there are added at the end of the entry in column 3 the words “or the prevention of these symptoms when associated with consuming food and drink”;

(d) in relation to the substance Sodium Cromoglycate, there are inserted in entry (b) in column 3, after the words “acute seasonal allergic conjunctivitis”, the words “or perennial allergic conjunctivitis”; and

(e) there is inserted in column 1, at the appropriate point in the alphabetical order of the entries in that column, each of the following substances—

(i) “Estramustine Sodium Phosphate”

• “Mizolastine”

• “Niceritrol”

• “Piroxicam Beta-cyclodextrin”

• “Torasemide”; and

(ii) “Insulin”.